欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Cenisertib_871357-89-0_产品详情
871357-89-0
  • names:

    Cenisertib

  • CAS号:

    871357-89-0

    MDL Number:
  • MF(分子式): C24H30FN7O MW(分子量): 451.54
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Cenisertib
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002205-10mg 10mg 99.56% ¥ 7425.00 ¥ 7425.00 2-3天
- +
¥ 0.00
YZM002205-5mg 5mg 99.56% ¥ 4550.00 ¥ 4550.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 871357-89-0
Inchi
InchiKey
分子式 Formula C24H30FN7O
分子量 Molecular Weight 451.54
溶解度Solubility 生物体外In Vitro:DMSO溶解度250 mg/mL(553.66 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
Cenisertib(CAS:871357-89-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 Cenisertib (AS-703569) 是一种有效的多激酶抑制剂,可抑制Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3的活性
IntroductionCenisertib (AS03569) is a multiinase inhibitor that blocks the activity of Aurorainase/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growthnhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia[2].
Application1
Application2
Application3
Cenisertib (AS-703569) 是一种有效的多激酶抑制剂,可抑制Aurora-kinase-A/B,ABL1,AKT,STAT5, FLT3的活性。 Cenisertib 通过抑制肿瘤肥大细胞 (MC) 中几种不同分子靶标的活性抑制其生长。 Cenisertib 抑制异种移植模型中胰腺癌,乳腺癌,结肠癌,卵巢癌和肺癌以及白血病的肿瘤生长。Cenisertib (AS-703569) is a multi-kinase inhibitor that blocks the activity ofAurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC)[1]. Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia[2].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Peter B, et al. Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. Leukemia. 2018 Apr;32(4):1016-1022.
【2】.McLaughlin J, et al. Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen. J Cancer Res Clin Oncol. 2010 Jan;136(1):99-113.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents